BioApp.dk ApS: Financial statements 2022
CVR: 41191325
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioApp.dk ApS (CVR 41191325) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,540,941 and a net result of DKK 581,181 compared with DKK 298,856 the year before. That is an increase of 58.9% compared with the year before. Equity in the 2022 report amounted to DKK 621,181. The solvency ratio was 56.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,540,941
- Profit/Loss
- DKK 581,181
- Equity
- DKK 621,181
- Total Assets
- DKK 1,100,112
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.5 mio. | 581 t. | 621 t. | 1 |
| 2021 | - | 970 t. | 299 t. | 339 t. | 1 |
| 2020 | - | 373 t. | 285 t. | 325 t. | 1 |
Official annual report
Keep an eye on BioApp.dk ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioApp.dk ApS has published its annual report for 2021. Gross profit came to DKK 969,862, and the net result was DKK 298,856.
About BioApp.dk ApS
BioApp.dk ApS is a Danish company of the type Anpartsselskab based in Odder, founded in 2020. The company is registered under the industry Anden måling og teknisk analyse. The management consists of Maks Klaustrup. The company is owned by BioApp Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,204,580 and a net result of DKK 321,371 compared with DKK -67,652 the year before. Equity in the 2025 report amounted to DKK 293,719.